Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Alamanos, Y.
Right arrow Articles by Drosos, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alamanos, Y.
Right arrow Articles by Drosos, A. A.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 1122-1123
© 2003 British Society for Rheumatology

Letters to the Editor

Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort

Y. Alamanos, P. V. Voulgari1, M. Papassava, K. Tsamandouraki and A. A. Drosos1,

Department of Hygiene and Epidemiology and
1 Division of Rheumatology, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece

The first 10% of the full text of this article appears below.

SIR, Studies carried out in different countries suggest significant variation in the survival rate of patients with systemic lupus erythematosus (SLE) [1, 2]. These findings could be related to different severity of the disease among populations, although access to efficient treatment and methodological differences among studies could explain these variations in part. Genetic, ethnic and environmental factors seem to be involved in the expression and severity of SLE [3–7].

The epidemiological and clinical profile of SLE . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?